SHARONBIO

Members of the Exchange are hereby informed that the admission to dealings in securities of Sharon Bio-Medicine Limited shall be withdrawn (delisted) w.e.f. February 20, 2024 pursuant to the Resolution Plan approved by the Hon'ble Mumbai Bench of National Company Law Tribunal (NCLT) under Section 31 of the Insolvency and Bankruptcy Code (IBC), 2016.

Sharon Bio-Medicine Limited has informed the Exchange that Record date for the purpose of Delisting of Shares pursuant to NCLT Order dated 17th May 2023 is 09-Jun-2023.

Sharon Bio-Medicine Limited has informed the Exchange that the Company has fixed Record Date as April 2, 2019 for the purpose of Reduction of Equity Share Capital of the Company pursuant to theResolution Plan approved by the Hon'ble National Company Law Tribunal

Sharon Bio-Medicine Limited has informed the Exchange that the Register of Members & Share Transfer Books of the Company will remain closed from September 20, 2016 to September 27, 2016 (both days inclusive) for the purpose of Annual General Meeting (AGM) of the Company to be held on September 27, 2016.

Sharon Bio-Medicine Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from December 25, 2015 to December 31, 2015 (both days inclusive) for the purpose of Annual General Meeting of the Company is scheduled to be held on December 31, 2015.

Sharon Bio-Medicine Limited has informed the Exchange that the Register of Members and Share Transfer Books of the Company shall remain closed from December 14, 2014 to December 17, 2014 for the purpose of Annual General Meeting to be held on December 17, 2014 and for ascertaining eligibility of the members for entitlement of final dividend.

Sharon Bio-Medicine Limited has informed the Exchange that the Company has fixed Record Date as February 21, 2014 for the purpose of Splitting / Sub-Division of each Equity Share of Face Value of Rs.10/- each into Five Equity Shares of Face value of Rs.2/- each and Issue of Fully Paid-up Bonus Shares in the ratio of 1:1 i.e., One Equity Share for every One Equity Share held on the record date.

Sharon Bio-Medicine Limited has informed the Exchange that the Board of Directors of the Company at its meeting held on January 14, 2014, has resolved the following, subject to the approval of the Members: (1) Increase in Authorised Share Capital from Rs. 20,25,00,000/- (Rupees Twenty Crores Twenty-Five Lakhs Only) to Rs. 35,00,00,000/- (Rupees Thirty Five Crores Only). (2) The sub-division of Equity Shares of face value of Rs. 10/- each to Rs. 2/- each. (3) Issuance of Bonus Equity Shares in the Ratio of 1:1. (4) Altering the Clauses in the Memorandum of Association and Articles of Associatio

Sharon Bio-Medicine Limited has informed the Exchange that the Company has fixed Book Closure from December 5, 2013 to December 9, 2013 for the purpose of ascertaining eligibility of the members for entitlement of final dividend. Further, the Annual General Meeting of the Company is scheduled to be held on December 09, 2013.

Sharon Bio-Medicine Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will remain closed from January 07, 2013 to January 08, 2013 for the purpose of ascertaining eligibility of the members for entitlement of final dividend of Rs. 1.80/- per Equity Share of Rs. 10/- each.

Sharon Bio-Medicine Limited has informed the Exchange that the Register of Members and the Share Transfer Books of the Company will remain closed from December 12, 2011 to December 19, 2011 for the purpose of ascertaining eligibility of the members for entitlemental of final dividend of Rs.1.80/- per Equity Share of Rs.10/- each and Annual General Meeting to be held on December 19, 2011.